6/9/25 We are currently making changes to reflect the new Health Sciences Division structure. Thank you for your patience while we make the transition.

Sign in
Temporary adalimumab dose escalation is effective in Crohn's disease patients with secondary non-response
Journal article   Peer reviewed

Temporary adalimumab dose escalation is effective in Crohn's disease patients with secondary non-response

K. Sutharshan and R.B. Gearry
Journal of Crohn's and colitis, Vol.7(7), pp.e277-e278
08/2013
Handle:
https://hdl.handle.net/10523/36956

Metrics

4 Record Views

Details

Logo image